Dechert advised Crossject, while Loeb & Loeb and Levine Keszler acted as legal advisors to Maxim Group LLC on the deal. Crossject, a pharmaceutical company specializing...
Crossject’s €7.2 Million Capital Increase and Issuance of Warrants
ARCHIMED’s Acquisition of FIM Medical
Dechert advised ARCHIMED on the deal. ARCHIMED, a leading international private equity player specializing in the healthcare sector, has acquired FIM Medical, a prominent player in...
Vestiaire Collective’s Crowdfunding Campaign
Dechert advised Vestiaire Collective on the deal. Vestiaire Collective, a leading second-hand fashion platform, announced its innovative crowdfunding campaign. Vestiaire Collective launched a crowdfunding campaign as...
Abivax’s €150 Million Financing
Dechert advised Abivax, Reed Smith advised Claret Capital Partners and Reinhart Marville Torre accompanied Kreos Capital and Claret Capital Partners in their investment. Abivax announced structured debt...
Abivax’s EUR 130 Million Cross-Over Financing
Gide advised financial advisers SVB Securities, LifeSci Capital and Bryan and Garnier & Co. The banks were also advised by Cooley LLP on aspects of US...
Gland Pharma’s EUR 120 Million Acquisition of Cenexi Group
Dechert advised Cathay Capital on the deal. Clifford Chance advised Gland Pharma. Indian generic injectables maker Gland Pharma Ltd (GLAD.NS) announced it will buy privately held French...
Abivax’ €49.2 Million Financing
Foley & Lardner LLP represented TCG Crossover on the deal while Dechert advised Abivax. TCG Crossover (TCGX) acted as the lead investor in the successful, oversubscribed EUR...
Vestiaire Collective’s Acquisition of Tradesy
Dechert advised Vestiaire Collective S.A. on the deal. Creditors were advised Gide. Tradesy was advised by Latham. Investors were advised by Joffe. Vestiaire Collective S.A. executed its...
ArchiMed’s Acquisition of Carso
The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...
Abivax’s €85 Million Funding Round
Dechert advised Abivax on the deal. Abivax, a Euronext Paris listed clinical-stage biotechnology company, executed its oversubscribed capital increase of €60 million and convertible bonds of...
Voyageurs du Monde’s €130 Million Financing Round
IN BRIEF: Allen & Overy, Dechert, advised on the matter. Allen & Overy advised Crédit Mutuel Equity with a team including Fr??ic Moreau (Corporate M&A), Romy...